Phase IMitochondrial Peptide
Compound 61494
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061494
Risk Class
MODERATE
Last Audit
Mar 8, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61494 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase i with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061494 with updates logged 2108-03-08.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61494Mitochondrial Peptide Program 61494
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061494
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61494